CompanyGraph
Beijing Wandong Medical Technology Co., Ltd.
600055 · SSE · China
wandong.com.cnFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $1.2B, above the global median of $1.15B
- FinancialsAltman Z-Score 5.05: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
8.11BCNY1.20B · vs all stocks (USD)
Revenue (TTM)
1.38BCNY205.00M · vs all stocks (USD)
Profit Margin
-20.20%vs Medical Devices peers
Beta
0.1150xvs all stocks
52-Week Change
-36.07%vs all stocks
Market Capitalization
8.11BCNY1.20B · vs all stocks (USD)
Enterprise Value
4.83BCNY716.85M · vs all stocks (USD)
Forward P/E
23.17xvs Medical Devices peers
Price to Sales (TTM)
5.55xvs Medical Devices peers
Price to Book (MRQ)
1.72xvs Medical Devices peers
Enterprise to Revenue
3.50xvs Medical Devices peers
Enterprise to EBITDA
-12.90xvs Medical Devices peers
Gross Margin
24.82%vs Medical Devices peers
Profit Margin
-20.20%vs Medical Devices peers
Operating Margin
-4.73%vs Medical Devices peers
Return on Assets (TTM)
-4.80%vs Medical Devices peers
Return on Equity (TTM)
-5.88%vs Medical Devices peers
Revenue (TTM)
1.38BCNY205.00M · vs all stocks (USD)
Revenue per Share (TTM)
1.97CNYUpdated Aug 20, 2026Quarterly Revenue Growth
8.90%vs Medical Devices peers
Gross Profit (TTM)
295.89MCNY43.95M · vs all stocks (USD)
EBITDA (TTM)
-374.08MCNY-55.56M · vs all stocks (USD)
Net Income (TTM)
-278.85MCNY-41.41M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
8.92%vs Medical Devices peers
Operating Cash Flow (TTM)
-273.33MCNY-40.59M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-182.54MCNY-27.11M · vs all stocks (USD)
5-Year Average Dividend Yield
0.69%vs all stocks
Payout Ratio
812.50%vs Medical Devices peers
Minority Interest (Equity)
110.51MCNYFY2025 · Dec 31, 2025Revenue
1.35BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
989.17MCNYFY2025 · Dec 31, 2025Gross Profit
357.82MCNYFY2025 · Dec 31, 2025Operating Income
-273.01MCNY-40.55M · vs all stocks (USD)
Pre-tax Income
-300.51MCNYFY2025 · Dec 31, 2025Income Tax Expense
-72.72MCNYFY2025 · Dec 31, 2025Net Income
-227.79MCNYFY2025 · Dec 31, 2025EBIT
-299.24MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-186.64MCNYFY2025 · Dec 31, 2025Research & Development
263.19MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
121.05MCNYFY2025 · Dec 31, 2025Other Operating Expenses
14.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
52.55MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.27MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.3200CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.3200CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
712.06MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
712.06MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-227.79MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-66.67KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-964.61MCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.06BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.82BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-227.79MCNYFY2025 · Dec 31, 2025Other Non-cash Items
14.62MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-233.16MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-518.27MCNYFY2025 · Dec 31, 2025Capital Expenditures
-98.97MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.68BCNYFY2025 · Dec 31, 2025Sale of Investments
2.96BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
175.35MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-91.40MCNYFY2025 · Dec 31, 2025Other Financing Charges
-5.96MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-97.36MCNYFY2025 · Dec 31, 2025Shares Outstanding
703.06MSharesUpdated Aug 20, 2026Float Shares
365.45MSharesUpdated Aug 20, 2026% Held by Insiders
51.48%vs all stocks
% Held by Institutions
4.51%vs all stocks
Total Cash (MRQ)
2.96BCNY440.00M · vs all stocks (USD)
Total Cash per Share (MRQ)
4.21CNYUpdated Aug 20, 2026Total Debt (MRQ)
22.02MCNY3.27M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0048xvs Medical Devices peers
Current Ratio (MRQ)
5.41xvs Medical Devices peers
Book Value per Share (MRQ)
6.32CNYUpdated Aug 20, 2026Total Assets
5.76BCNY855.35M · vs all stocks (USD)
Total Current Assets
4.61BCNYFY2025 · Dec 31, 2025Total Liabilities
1.19BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.15BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
42.99MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.15BCNYFY2025 · Dec 31, 2025Cash
3.13BCNYFY2025 · Dec 31, 2025Cash Equivalents
141.15MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.27BCNYFY2025 · Dec 31, 2025Accounts Receivable
437.57MCNYFY2025 · Dec 31, 2025Inventory
637.47MCNYFY2025 · Dec 31, 2025Accounts Payable
791.08MCNYFY2025 · Dec 31, 2025Short-term Debt
8.11MCNYFY2025 · Dec 31, 2025Other Current Liabilities
59.64MCNYFY2025 · Dec 31, 2025Long-term Debt
15.71MCNYFY2025 · Dec 31, 2025Common Stock (Book)
703.06MCNYFY2025 · Dec 31, 2025Retained Earnings
739.06MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.57BCNY678.48M · vs all stocks (USD)
Treasury Stock
30.00MCNYFY2025 · Dec 31, 202552-Week Low
9.83CNYUpdated Aug 20, 202652-Week High
18.88CNYUpdated Aug 20, 202652-Week Change
-36.07%vs all stocks
Beta
0.1150xvs all stocks
50-Day MA
11.04CNYUpdated Aug 20, 2026200-Day MA
14.18CNYUpdated Aug 20, 2026Avg 10-Day Volume
6.36MSharesUpdated Aug 20, 2026Avg 30-Day Volume
7.16MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
-0.3900CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.05: safe zoneNotable
Altman Z-Score: 5.05
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $1.2B, above the global median of $1.15BNotable
Market cap (USD): 1,204,990,970.929Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Chengdu Easton Bio Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shandong Lukang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiuzhitang Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Artivion Inc.
Tier 1ProductionApproval-Gated PipelineRule
Carsgen Therapeutics Holdings Limited
Tier 1ProductionApproval-Gated PipelineRule
Alpha Tau Medical Ltd.
Tier 1ProductionApproval-Gated PipelineRule
QuidelOrtho Corporation
Tier 1ProductionApproval-Gated PipelineRule
Kissei Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Sunflower Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangzhou Wondfo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule